The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy | Haematologica
Full article: Anti-CD20 treatment for B-cell malignancies: current status and future directions
Establishment of C20Mab‑11, a novel anti‑CD20 monoclonal antibody, for the detection of B cells
Mechanisms of action of anti-CD20 monoclonal antibodies. Abbreviation:... | Download Scientific Diagram
Laurent ARNAUD on X: "Interesting review 🔎 about #CD20 and anti-CD20 #treatments such as #rituximab or #obinutuzumab which are important drugs in the management of systemic #lupus 🐺 #openaccess 🔓 Link: https://t.co/pkzmhYIca4" /
Protéine CD20 pleine longueur exprimée HEK293 avec Nanodisc / DDM / VLP - ACROBiosystems
Characteristics of selected anti-CD20 monoclonal antibodies | Download Table
Combining schematic of different effector mechanisms of anti CD20 mAbs... | Download Scientific Diagram
Potential anti-CD20 mAb effector mechanisms. (A) Fc-Fc ␥ R–dependent... | Download Scientific Diagram
Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance | Oncogene
Brain Sciences | Free Full-Text | Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab
Anti-CD20 antibody rituximab in the treatment of rheumatoid arthritis. | Semantic Scholar
iLite® CD20 (+) Target
Learning multiple sclerosis immunopathogenesis from anti-CD20 therapy | PNAS
Lymphoma: Radioimmunotherapy Using Iodine-131 Labeled Murine Anti-CD20 Antibodies (131I-Tositumomab and Tositumomab, “Bexxar”) | Radiology Key
Anticorps monoclonal anti-CD20 (rituximab) dans les maladies hématologiques et les affections auto-immunes - ScienceDirect
Noninvasive Evaluation of CD20 Expression Using 64Cu-Labeled F(ab′)2 Fragments of Obinutuzumab in Lymphoma | Journal of Nuclear Medicine
Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance | Oncogene
Anti-CD20 Monoclonal Antibodies for Relapsing and Progressive Multiple Sclerosis | CNS Drugs
CD20 Anticorps (FITC-65085) | Proteintech
Development of Anti-CD20 Antigen-Targeting Therapies for B-cell Lymphoproliferative Malignancies - The State of the Art | Bentham Science
Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action - Pescovitz - 2006 - American Journal of Transplantation - Wiley Online Library
Frontiers | Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?
Anti-CD20 Antibody Therapy for B-Cell Lymphomas | NEJM
anti-CD20 (Rituximab) - ACE Biolabs Antibody │ Chemical │ Enzyme
![Anti-CD20 Anticorps [2H7] (APC) (A85690) | Antibodies.com](https://cdn.antibodies.com/image/catalog/85/A85690_157.jpg?profile=product_top "Anti-CD20 Anticorps [2H7] (APC) (A85690) | Antibodies.com")
Anti-CD20 Anticorps [2H7] (APC) (A85690) | Antibodies.com
